The Washington Post

New at the top: Linda L. Chang

The road I’ve been on is not one that is frequently traveled. I was raised in Taiwan, the oldest of six girls. That made for tight financial resources. Upon moving to the United States when I was a teenager, I didn’t even know the alphabet.

Early on, I was always on survival mode. I wanted to make sure that I got on par with my peers as quickly as I could.

But there were challenges to that. Even though I was at the top of my class in Taiwan, I remember during the first PTA meeting in the States my teacher recommended that I get a medical checkup because they said I wasn’t responding. They didn’t know that I just didn’t speak any English.

It was that kind of environment that gave me the determination to stay calm and patient but to have that quiet resolve. I knew I wasn’t in a situation where the world was open to me or the sky was the limit — especially being raised in a traditional home where women weren’t always expected to excel outside of the home. I wanted more for my life. Being independent is important. Plus, I wanted to be an equally contributing partner.

So I decided to go to college. When my husband did a post doctorate in Georgia, I pursued two masters degrees at the same time. It helped me figure out what area I wanted to go into. Then I got my CPA designation and started with a pharmaceutical company.

Linda Chang is the new chief financial officer of PharmAthene. (Photo by Marshall Clarke)

I did a five-year stint in management consulting at Grant Thornton and Booz Allen, supporting both government and private clients in health care and information technology.

Because I was exposed to a lot of different modes of operations, there were a lot of lessons learned. I developed project management skills, how to perform an engagement, how to frame the questions, how to analyze the alternatives, and execution.

I transitioned to Human Genome Sciences for 11 years, eventually becoming a senior director of finance.

Through one mechanism or another, we raised capital and monetized assets to have sufficient resources for the company to develop a list of products such as the first lupus drug approved by the Federal Drug Administration in more than 50 years.

We raised $1.8 billion in equity and restructured more than $600 million in convertible debt over that time.

Because of my background, I am so appreciative to the people who lent a hand to me.

The chief financial officer at HGS who hired me was a great mentor. He looked beyond the typical stereotypes and helped shape my thinking in the business world.

He taught me that the more perspectives you can bring to analyze a situation, the better the decision-making process will be. I apply that method almost always.

In terms of my career path, I have experience and background that are relevant to PharmAthene. I look forward to contributing in whatever way I can with the analytical, decision-making or execution approach that I’ve learned along the way in pharmacy care.

— Interview with Vanessa Small

Linda L. Chang

Position: Senior vice president and chief financial officer of PharmAthene, a biotechnology company based in Annapolis.

Career highlights: Senior director of finance, Human Genome Sciences; associate, Booz Allen & Hamilton; associate, Grant Thornton.

Age: 45

Education: BS, Business Administration, University of California, Riverside; MBA, Accounting and Health Administration, University of Georgia; CPA

Personal: Resides in Gaithersburg with husband.



Success! Check your inbox for details. You might also like:

Please enter a valid email address

See all newsletters

Show Comments
Most Read



Success! Check your inbox for details.

See all newsletters

Your Three. Video curated for you.

To keep reading, please enter your email address.

You’ll also receive from The Washington Post:
  • A free 6-week digital subscription
  • Our daily newsletter in your inbox

Please enter a valid email address

I have read and agree to the Terms of Service and Privacy Policy.

Please indicate agreement.

Thank you.

Check your inbox. We’ve sent an email explaining how to set up an account and activate your free digital subscription.